Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Citizens
Tweet Send to a Friend
Citizens analyst Jason Butler raised the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $25.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
